Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
Titel:
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
Auteur:
Iannone, Florenzo Courvoisier, Delphine S. Gottenberg, Jacques Eric Hernandez, Maria Victoria Lie, Elisabeth Canhão, Helena Pavelka, Karel Hetland, Merete Lund Turesson, Carl Mariette, Xavier Choquette, Denis Finckh, Axel